Translational Breast Cancer Research Award
The objective of the Translational Breast Cancer Research Award is to support research in the biology, prevention, detection, diagnosis, and/or treatment of breast cancer.
Grant Program Contacts:
Application process, requirements, eligibility:
Jessica Raines-Jones
Research Development Coordinator
612-624-8679
[email protected]
Applicability of research:
Carol Lange, PhD
[email protected]
Grantees
David Masopust, PhD
PELP1/phosphor-SRC-3 complexes promote breast cancer stem cell expansion
Julie Ostrander, PhD, Department of Medicine, Medical School
Novel methods for discovering genetic interactions underlying breast cancer risk
Chad Myers, PhD, Department of Computer Science and Engineering, College of Science and Engineering
Novel MR Imaging Biomarkers for IGF1R Targeted Drugs for Breast Cancer Metastasis
Deepali Sachdev, PhD, Department of Medicine, Medical School
Novel Mechanisms of Tumor-Promoting Inflammation during Breast Tumorigenesis
Kaylee Schwertfeger, PhD, Department of Laboratory Medicine and Pathology, Medical School
Cytoplasmic PELP1 Protein Interactions Promote Activation of Ras and NF-Kb
Julie Ostrander, PhD, Department of Medicine, Medical School
Methylation Based Biomarkers for Early Detection of Breast Cancer
Bharat Thyagarajan, PhD, Department of Laboratory Medicine and Pathology, Medical School
A New Model for Studying Collective Cell Migration and Invasion in Breast Cancer
Elizabeth Wattenberg, PhD, Division of Environmental Health Sciences, School of Public Health
Identification and Characterization of Novel Inhibitors of FGF Signaling
Anindya Bachi, PhD, Department of Urology, Medical School
Role of Fanconi Anemia/Breast Cancer Associated Proteins FANCD2 and FANCI in DNA Lesion Repair
Alexandra Sobeck, PhD, Department of Biochemistry, Molecular Biology and Biophysics, College of Biological Sciences